ZA911343B - Method for the immunological determination of ligands - Google Patents

Method for the immunological determination of ligands

Info

Publication number
ZA911343B
ZA911343B ZA911343A ZA911343A ZA911343B ZA 911343 B ZA911343 B ZA 911343B ZA 911343 A ZA911343 A ZA 911343A ZA 911343 A ZA911343 A ZA 911343A ZA 911343 B ZA911343 B ZA 911343B
Authority
ZA
South Africa
Prior art keywords
binding
ligand
determined
immunological determination
ligands
Prior art date
Application number
ZA911343A
Inventor
Arno Dr Deger
Deger Dr Arno
Roland Dr Schenk
Schenk Dr Roland
Gerhard Dr Bienhaus
Bienhaus Dr Gerhard
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA911343B publication Critical patent/ZA911343B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Method for the immunological determination of a ligand, in which the ligand to be determined is reacted with a) at least 2 molecules of a substance P2 which is capable of specific binding, with at least one of these molecules carrying a label, and b) a receptor R which consists of a binding partner P1 which is capable of monovalent binding with P2, and of a binding site R1 for the ligand to be determined, and then the label is determined, and a reagent for the immunological determination of a ligand, which contains a substance P2 which is capable of specific binding and is at least partially in labelled form, and a receptor R which consists of a binding partner P1 which is capable of monovalent binding with P2 and of a binding site R1 for the ligand to be determined.
ZA911343A 1990-02-26 1991-02-25 Method for the immunological determination of ligands ZA911343B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4006054A DE4006054A1 (en) 1990-02-26 1990-02-26 METHOD FOR THE IMMUNOLOGICAL DETERMINATION OF LIGANDS

Publications (1)

Publication Number Publication Date
ZA911343B true ZA911343B (en) 1991-11-27

Family

ID=6401009

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA911343A ZA911343B (en) 1990-02-26 1991-02-25 Method for the immunological determination of ligands

Country Status (9)

Country Link
EP (1) EP0444561B1 (en)
JP (1) JP2501960B2 (en)
KR (1) KR940008091B1 (en)
AT (1) ATE145479T1 (en)
AU (1) AU647449B2 (en)
CA (1) CA2034922A1 (en)
DE (2) DE4006054A1 (en)
ES (1) ES2096596T3 (en)
ZA (1) ZA911343B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138251B1 (en) 1996-04-22 2006-11-21 Amgen Inc. Polynucleotides encoding a neurotrophic factor receptor
JP2002505576A (en) * 1997-05-30 2002-02-19 アムジエン・インコーポレーテツド Neurotrophic factor receptor
EP1695083A1 (en) 2003-12-01 2006-08-30 Dade Behring Marburg GmbH Homogeneous detection method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5510590A (en) * 1978-05-04 1980-01-25 Wellcome Found Enzyme immunity quantity analysis
US4228237A (en) * 1978-09-21 1980-10-14 Calbiochem-Behring Corp. Methods for the detection and determination of ligands
US4495296A (en) * 1979-05-21 1985-01-22 New York Blood Center, Inc. Labeled anti-hapten antibodies and their use as a universal reagent for solid phase radio- and/or enzyme-immunoassays
NZ211888A (en) * 1984-05-10 1987-08-31 Abbott Lab Biotin-antibiotin immunoassay for detecting ligands
JPS60252265A (en) * 1984-05-29 1985-12-12 Toray Ind Inc Light emitting reagent and method for measuring biologically active material using said reagent
IE64286B1 (en) * 1988-05-25 1995-07-26 Boehringer Mannheim Gmbh Process for the determination of an immunologically detectable substance and a suitable vessel therefor
DE3834766A1 (en) * 1988-10-12 1990-04-26 Boehringer Mannheim Gmbh METHOD FOR DETERMINING A SPECIFICALLY BINDABLE SUBSTANCE

Also Published As

Publication number Publication date
EP0444561A2 (en) 1991-09-04
ES2096596T3 (en) 1997-03-16
DE59108355D1 (en) 1997-01-02
KR940008091B1 (en) 1994-09-02
EP0444561B1 (en) 1996-11-20
CA2034922A1 (en) 1991-08-27
ATE145479T1 (en) 1996-12-15
DE4006054A1 (en) 1991-08-29
KR910021586A (en) 1991-12-20
JPH04216465A (en) 1992-08-06
EP0444561A3 (en) 1992-10-14
AU7101391A (en) 1991-08-29
JP2501960B2 (en) 1996-05-29
AU647449B2 (en) 1994-03-24

Similar Documents

Publication Publication Date Title
ZA891568B (en) Method for determination of a polyvalent substance using an immunoaggregate
GR3024598T3 (en) Metal complexes of acid adducts to dioxime ligands useful in labelling proteins and other amine-containing compounds
EP0407904A3 (en) Method for the determination of an analyte
DE59409947D1 (en) Reduction of the hook effect in immunoassays with particulate carrier material
DE3480494D1 (en) Method and reagent for use in the assay of pivka-ii
ATE67599T1 (en) HETEROGENOUS IMMUNOASSAY.
EP0444561A3 (en) Method for the immunological determination of ligands
ES8605106A1 (en) Process and reagent for the quantitative determination of free thyroxine in plasma, serum and full blood.
GR3009564T3 (en)
NO862430D0 (en) HISTAMINE DERIVATIVES, IMMUNOGEN CONJUGATES AND ANTIBODIES CREATED AGAINST THESE.
GR3005066T3 (en)
AU1718588A (en) Method for the determination of albumin in biological fluids
DE3172795D1 (en) Process for the determination of ligands, test kit for carrying out the process and its application
PT1104888E (en) Method for identifying ligands that specifically bind to growth hormone releasing hormone receptor
EP0276719A3 (en) Immunoassay utilizing microparticle neutralization
EP0407605A4 (en) Reagent for detecting antibody corresponding to acid-fast bacterium antigen and application thereof
DE3468324D1 (en) Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems
DE3478346D1 (en) Method for assaying basic fetoprotein and reagent therefor
DE3365111D1 (en) Labelled conjugates of ethosuximide, ethosuximide immunogens, antibodies thereto, immunoassay method employing the antibodies and reagent means, test kit and test device for the immunoassay method
EP0650054A3 (en) Process and device for obtaining and detecting immunologically reactive substances from the gas phase.
JPS5386014A (en) Quantitative analysis of antigen and antibody
HUT61619A (en) Method for radioimmunological derminic 5-hydroxi- 6,8,11,14-eicosatetraen- acid content of the biological samples
DE59708051D1 (en) Stabilization of standard solutions using conjugates